DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts" report to their offering.
Transdermal Drug Delivery Partnering 2010-2017 report provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world's leading healthcare companies since 2010.
The report takes the reader through a comprehensive review Transdermal Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Transdermal Drug Delivery partnering deals.
The report presents financial deal term values for Transdermal Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
Key benefits:
- In-depth understanding of Transdermal Drug Delivery deal trends since 2010
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of Transdermal Drug Delivery agreements with numerous real life case studies
- Detailed access to actual Transdermal Drug Delivery contracts entered into by leading biopharma companies
- Identify most active Transdermal Drug Delivery dealmakers since 2010
- Insight into terms included in a Transdermal Drug Delivery partnering agreement, with real world examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Deal trends, players, financials and forecasts, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Transdermal Drug Delivery dealmaking
Chapter 3 - Leading Transdermal Drug Delivery deals
Chapter 4 - Most active Transdermal Drug Delivery dealmakers
Chapter 5 - Transdermal Drug Delivery contracts dealmaking directory
Chapter 6 - Transdermal Drug Delivery dealmaking by technology type
For more information about this report visit http://www.researchandmarkets.com/research/t5x4jx/global
